Non-Invasive Alternative to Surgery For patients unwilling or ineligible for bariatric surgery, GLP-1 therapy provides a less invasive and safer option for achieving significant weight loss without surgical intervention
At Karespot, eligible adults can access a doctor-led metabolic and weight management pathway in India that combines medical review, prescription treatment when appropriate, and long-term support
Enhanced with Vitamin D3
This is about the same price as 4, 0.75 mL of 2.4 mg/0.75 mL pens of Wegovy, but around $300 more expensive than 4, 0.5 mL of 5 mg/0.5 mL pens of Zepbound (tirzepatide)
Nihon Rinsho Meneki Gakkai Kaishi
While semaglutide activates only the GLP-1 receptor, tirzepatide targets both GLP-1 and GIP receptors, creating a synergistic effect that clinical trials show produces greater weight reduction in many patients